What does IALT mean in MEDICAL
IALT stands for the International Adjuvant Lung Cancer Trial. It is a collaborative clinical research study carried out to evaluate the effectiveness of adjuvant chemotherapy in treating patients diagnosed with non-small cell lung cancer (NSCLC). This trial was established in 1992 and has been conducted at multiple sites in Europe, South America, North America and Asia. Results from this trial have expanded our understanding of the benefits of chemotherapy for NSCLC patients, leading to changes in how these individuals are treated.
IALT meaning in Medical in Medical
IALT mostly used in an acronym Medical in Category Medical that means International Adjuvant Lung Cancer Trial
Shorthand: IALT,
Full Form: International Adjuvant Lung Cancer Trial
For more information of "International Adjuvant Lung Cancer Trial", see the section below.
Definition
The IALT is a multi-country collaboration that aims to evaluate the role of chemotherapy as an additional therapy following surgery for early stage non-small cell lung cancer (NSCLC). Chemotherapy is a treatment approach that uses drugs to kill cancer cells. The IALT has looked at several different types of chemotherapy and compared them to a control group who are receiving no additional treatment after surgical removal of the lung tumor. By comparing outcomes between those receiving chemotherapy versus not receiving it, researchers can determine which treatments may be most effective for early stage NSCLC patients.
Significance
The results of IALT showed that adding chemotherapy to the treatment plan for certain individuals with early stage NSCLC improved their chances of survival over those who did not receive any additional therapy after surgery. Additionally, researchers discovered more information about which types and combinations of chemotherapy drugs offered the best results for different types of NSCLC tumors. These findings have helped inform treatment decisions by oncologists around the world with regards to which patients should or should not undergo adjuvant chemotherapy following surgery. Ultimately, these important insights have contributed significantly to improving outcomes for individuals battling lung cancer worldwide.
Essential Questions and Answers on International Adjuvant Lung Cancer Trial in "MEDICAL»MEDICAL"
What is the International Adjuvant Lung Cancer Trial?
The International Adjuvant Lung Cancer Trial (IALT) is an international study aiming to improve lung cancer treatments. Specifically, it seeks to compare various treatments for early-stage non-small cell lung cancer (NSCLC) which includes chemotherapy, radiation therapy and newer, targeted medications.
Who can be a part of the IALT trial?
The IALT seeks people who are newly diagnosed with early-stage non-small cell lung cancer (NSCLC). Candidates must meet certain criteria to be eligible for the trial including age, type of cancer, surgical treatment already received and more.
What kind of treatments will be studied in this trial?
The IALT will evaluate chemotherapy drugs, radiation therapy and newer types of targeted medications as potential treatments for early-stage NSCLC.
How long does the IALT trial last?
Participation in the IALT can take up to 6 years depending on when participants join. Participants are actively followed during this time through clinic visits, phone calls or emails about their progress every 3 months or so.
What are the risks associated with being enrolled in the IALT?
As with any medical research study that involves taking medication and other forms of care, there may be risks associated with enrolment in the IALT such as side effects from medications or complications from tests or procedures which may be required during participation in the trial. These risks should always be discussed with a medical professional before making any decisions about enrolling in an experimental medical trial.
What are the benefits of enrolling in IALT?
Participation in this clinical trial could lead to access to novel therapies not yet available outside of research trials. It also provides participants with regular monitoring by highly experienced professionals who are dedicated to finding better ways to treat and prevent lung cancer.
Final Words:
The International Adjuvant Lung Cancer Trial has been an incredibly important project helping improve outcomes for individuals with early stage non-small cell lung cancer through evaluation of adjuvant therapies such as chemotherapy. Its impact has been felt around the world as doctors continue to rely on its findings when making decisions regarding treatments plans for their patients today - a testament to its significance and importance within the global clinical research community.
IALT also stands for: |
|
| All stands for IALT |